The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Zydus Lifesciences shares surged 7% to an intraday high of Rs 947.95 on the BSE on Thursday after receiving final approval ...

Zydus Lifesciences Ltd is quoting at Rs 906.2, up 2.11% on the day as on 12:49 IST on the NSE. The stock is down 7.22% in last one year as compared to a 0.19% fall in NIFTY and a 6.32% fall in the ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...

Benchmark BSE Sensex surged by 740 points while Nifty snapped its 10-day losing streak on Wednesday (March 5) following value ...

The company launched ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients. ANVIMO will ...

Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

On March 6, several key stocks are in focus. TCS has partnered with Vantage Towers to launch a digital service platform aimed at enhancing property owner experiences in telecom tower leasing. LIC ...

AM(IST)on Thursday in an upbeat market. Gland Pharma Ltd.(up 3.66 per cent), Zydus Lifesciences Ltd.(up 3.17 per cent), ...

Stocks including TCS, Wipro, Dalmia Bharat, Zydus Life, LIC Housing, Hindustan Zinc, R Systems, Zaggle Prepaid, IRFC and ...

The NSE Nifty 50 has left bearish gaps in the range of 22,450–22,514 and 22,668–22,720, which will act as strong hurdles in ...

IT services company TCS has collaborated with Vantage Towers, Europe’s second-largest telecom tower operator, to introduce a ...